Olema Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Olema Pharmaceuticals generated cash of -$83,727,000, which is less than the previous year. Cash used in financing activities reached the amount of $133,415,000 last year. Net change in cash is therefore $44,837,000.
Cash Flow
| 2018 | -2.17M | 0 | 5.25M |
|---|---|---|---|
| 2019 | -3.08M | 0 | 0 |
| 2020 | -19.86M | -56K | 358.40M |
| 2021 | -50.69M | -275.43M | 1.39M |
| 2022 | -82.06M | 91.47M | 476K |
| 2023 | -83.72M | -4.85M | 133.41M |
OLMA Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 23.70M | 13.81M | 338.54M | 68K | 3.14M | 71K |
Operating activities | ||||||
Net income | -96.65M | -104.78M | -71.09M | -22.12M | -4.31M | -2.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 377K | 357K | 163K | 11K | 9K | 8K |
Stock-based compensation expense | 17.25M | 18.82M | 15.91M | 3.10M | 0 | 0 |
| Deferred income tax benefit | 17.25M | 18.82M | 15.91M | 3.10M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.32M | 351K | -683K | -220K | 1.16M | -100K |
Cash generated by operating activities | -83.72M | -82.06M | -50.69M | -19.86M | -3.08M | -2.17M |
Investing activities | ||||||
Purchases Of Investments | -255.62M | -213.66M | -486.96M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -363K | -1.57M | -56K | 0 | 0 |
Acquisitions Net | 0 | 363K | 1.57M | 0 | 0 | 0 |
Cash generated by investing activities | -4.85M | 91.47M | -275.43M | -56K | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 129.73M | 330K | 721K | 220.55M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -2.28M | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -3.08M | 0 | 0 |
Cash used in financing activities | 133.41M | 476K | 1.39M | 358.40M | 0 | 5.25M |
Net Change In Cash | 44.83M | 9.89M | -324.73M | 338.48M | -3.08M | 3.07M |
Cash at end of period | 68.53M | 23.70M | 13.81M | 338.54M | 68K | 3.14M |
| Data source | Data source | Data source | Data source |